Clinical Trial Update: Phase III Study of Intramuscular TAK-816 in Healthy Infants [Phase 3]

View source ↗

Summary

Phase III trial evaluating intramuscular TAK-816 for prevention of Haemophilus influenzae type B disease in infants was completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• TAK-816

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers, Haemophilus Influenzae Type b, Prevention | Phase 3 | Status: COMPLETED | Results posted: 2016-04-26